ViiV, Halozyme collaborate on Enhanze drug delivery technology for HIV medicines
ViiV Healthcare, a GSK company that is specialised in HIV therapies, has entered into a global collaboration and license agreement with Halozyme Therapeutics for the latter’s Enhanze drug